Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients.
To compare the efficacy of two atypical antipsychotic drugs, olanzapine and risperidone, in schizophrenic patients with post-psychotic depression. A clinically significant decrease of MADRS scores occurred in patients treated with both drugs for 8 weeks. Atypical antipsychotic drugs may be particularly appropriate when treating schizophrenic patients with depression.